Doctor of global public health. He has 20 years of experience in epidemiological research, phase I-IV clinical research, and CTD development. The main scientific achievement was the development of a new recombinant Cyd-TDV vaccine. He has extensive experience in conducting clinical trials in Asia. Dr. Ankh Vartel's main research interests are related to vaccines against viruses, bacteria, and parasites. He has extensive experience in epidemiological and clinical research, both in academia and in the pharmaceutical industry. Dr. T. Anh Wartel has been conducting clinical drug research for almost 20 years and has made extensive use of vaccines in the areas of public health, global health, and infectious diseases.